SCHEMBL3640394

SCHEMBL3640394

O=S(=O)(Nc1nccs1)c1ccc(Nc2nc(CCOc3ccccc3)cs2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.55
ADRB1 P08588 1/20 0.55
ADRB3 P13945 1/20 0.55
PKM P14618 4/20 0.52
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SCN3A Q9NY46 2/20 0.50
SCN1A P35498 2/20 0.50
SCN5A Q14524 2/20 0.50
SCN8A Q9UQD0 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
EGFR P00533 1/20 0.50
KDR P35968 1/20 0.50
SCN1B Q07699 1/20 0.50
POLB P06746 2/20 0.49
CCNT1 O60563 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL712533 0.95 ADRB2 (0.59) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL710350 0.90 PKM (0.54) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL713201 0.89 PKM (0.48) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL711721 0.86 LMNA (0.56) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL711654 0.84 SCN1A (0.59) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL713208 0.83 ADRB2 (0.57) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL713129 0.81 LMNA (0.60) PKMALDH1A1MEN1KMT2ASCN3A
SCHEMBL714306 0.80 SCN1A (0.56) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL711980 0.80 SCN1A (0.54) ADRB2ADRB1ADRB3PKMALDH1A1
SCHEMBL713846 0.79 SCN1A (0.56) ADRB2ADRB1ADRB3PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed